Cargando…
Gaucher disease: Biochemical and molecular findings in 141 patients diagnosed in Greece
Gaucher disease (GD) is characterized by a marked phenotypic and genetic diversity. It is caused by the functional deficiency of the lysosomal enzyme β-glucocerebrosidase (GCase), which in most instances results from mutations in the GBA1 gene and over 500 different disease causing mutations have be...
Autores principales: | Dimitriou, Evangelia, Moraitou, Marina, Cozar, Mónica, Serra-Vinardell, Jenny, Vilageliu, Lluïsa, Grinberg, Daniel, Mavridou, Irene, Michelakakis, Helen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284128/ https://www.ncbi.nlm.nih.gov/pubmed/32547927 http://dx.doi.org/10.1016/j.ymgmr.2020.100614 |
Ejemplares similares
-
A novel mutation deep within intron 7 of the GBA gene causes Gaucher disease
por: Malekkou, Anna, et al.
Publicado: (2020) -
Prevalence of antibodies to ganglioside and Hep 2 in Gaucher, Niemann – Pick type C and Sanfilippo diseases
por: Dimitriou, Evangelia, et al.
Publicado: (2019) -
Mapping the genetic and clinical characteristics of Gaucher disease in the Iberian Peninsula
por: Giraldo, Pilar, et al.
Publicado: (2012) -
EXTL2 and EXTL3 inhibition with siRNAs as a promising substrate reduction therapy for Sanfilippo C syndrome
por: Canals, Isaac, et al.
Publicado: (2015) -
a-Synuclein and lipids in erythrocytes of Gaucher disease carriers and patients before and after enzyme replacement therapy
por: Moraitou, Marina, et al.
Publicado: (2023)